Your browser doesn't support javascript.
loading
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier, Jeffrey S; Khanani, Arshad M; Quezada Ruiz, Carlos; Basu, Karen; Ferrone, Philip J; Brittain, Christopher; Figueroa, Marta S; Lin, Hugh; Holz, Frank G; Patel, Vaibhavi; Lai, Timothy Y Y; Silverman, David; Regillo, Carl; Swaminathan, Balakumar; Viola, Francesco; Cheung, Chui Ming Gemmy; Wong, Tien Y.
Afiliação
  • Heier JS; Ophthalmic Consultants of Boston, Boston, MA, USA. Electronic address: JSHEIER@eyeboston.com.
  • Khanani AM; Sierra Eye Associates, Reno, NV, USA; The University of Nevada, Reno School of Medicine, Reno, NV, USA.
  • Quezada Ruiz C; Clinica de Ojos Garza Viejo, San Pedro Garza Garcia, Nuevo Leon, Mexico; Genentech, South San Francisco, CA, USA.
  • Basu K; Roche Products (Ireland), Dublin, Ireland.
  • Ferrone PJ; Vitreoretinal Consultants of New York, Great Neck, NY, USA.
  • Brittain C; Genentech, South San Francisco, CA, USA.
  • Figueroa MS; Clinica Baviera, Ramon y Cajal University Hospital, Madrid, Spain.
  • Lin H; Genentech, South San Francisco, CA, USA.
  • Holz FG; Department of Ophthalmology and GRADE Reading Center, University of Bonn, Bonn, Germany.
  • Patel V; Roche Products, Welwyn Garden City, UK.
  • Lai TYY; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Silverman D; Roche Products, Welwyn Garden City, UK.
  • Regillo C; Mid Atlantic Retina, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.
  • Swaminathan B; Hoffmann-La Roche, Mississauga, ON, Canada.
  • Viola F; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Cheung CMG; Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, Singapore.
  • Wong TY; Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, Singapore.
Lancet ; 399(10326): 729-740, 2022 02 19.
Article em En | MEDLINE | ID: mdl-35085502
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Inibidores da Angiogênese / Angiopoietina-2 / Fator A de Crescimento do Endotélio Vascular / Degeneração Macular Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Inibidores da Angiogênese / Angiopoietina-2 / Fator A de Crescimento do Endotélio Vascular / Degeneração Macular Idioma: En Ano de publicação: 2022 Tipo de documento: Article